Dr. Sanjay Gupta returns to one of the most consequential beats of his career tonight, April 19, 2026, as CNN premieres Weed 8: Women and Weed at 8 p.m. ET/PT. The eighth installment in Gupta's long-running cannabis documentary series shifts the lens from policy and pharmacology to a population that is now driving much of the modern cannabis economy — women.

For a series that began more than a decade ago with Gupta publicly reversing his own skepticism about medical marijuana, Weed 8 arrives at a fitting cultural moment. Recent industry data shows women have, for the first time, slightly outpaced men as cannabis consumers in the United States, and the pipeline of women-led cannabis brands, advocacy networks, and clinical research programs has matured into a force the broader industry can no longer treat as a niche.

Advertisement

What "Weed 8" Covers

According to CNN's press materials, the special travels primarily to Oklahoma, where the legalization of medical marijuana in 2018 sparked a fast-moving "green rush" and produced one of the most accessible medical cannabis markets in the country. Gupta uses Oklahoma as a case study in how women have become entrepreneurs, consumers, and advocates at the center of an industry that for decades treated them as an afterthought.

The hour interweaves three storylines. First, Gupta embeds with communities of "Cannamoms" — women who gather socially to consume cannabis, share parenting and wellness experiences, and host educational events designed to demystify cannabis for adults navigating careers, motherhood, and middle age. Second, he reports from the annual Cowboy Cup, a juried cannabis competition and culture festival that has emerged as Oklahoma's marquee industry event and showcases the scale and diversity of the state's regulated market. Third, he sits down with researchers studying the rise in cannabis use during pregnancy and its potential effects on prenatal brain development — a sensitive scientific frontier that Gupta has consistently been willing to examine head-on.

The "Grass Ceiling" Frame

The phrase "grass ceiling" — a play on the corporate "glass ceiling" used to describe barriers to women's advancement — has become shorthand within the cannabis industry for the gap between women's growing consumer power and their still-uneven representation in cannabis ownership, executive ranks, and capital allocation.

Industry surveys over the past several years have consistently shown that women own a smaller share of cannabis businesses than the broader U.S. small-business average, and that female-founded brands raise meaningfully less venture capital than their male-founded counterparts despite often outperforming on customer retention and gross margin. Weed 8's framing argues that this gap is now actively closing — but unevenly — as women shift from cannabis consumers to cannabis founders, regulators, and clinicians.

Why CNN Returning to Cannabis Matters

When Gupta aired the original Weed in 2013, the political ground beneath cannabis policy was nothing like today's. Only a handful of states had medical programs. Recreational legalization was a Colorado-Washington experiment that mainstream physicians and federal policymakers viewed with deep suspicion. Gupta's on-camera apology — for years of opposing medical cannabis based on what he came to see as incomplete reading of the evidence — was a watershed moment that helped move medical marijuana into the mainstream of American medicine.

Each subsequent installment has functioned as both a status update on cannabis science and a barometer of cultural acceptance. Weed 8 lands in a year when 25 states plus the District of Columbia have legal adult-use markets, when President Trump has issued an executive order pushing federal Schedule III reclassification, and when the largest entertainment arena in the United States — Chicago's United Center — now sells hemp-derived THC beverages alongside beer.

By focusing this installment on women, Gupta is signaling that the next chapter of the cannabis story is less about whether the plant should be legal and more about who gets to define the legal industry. That shift has consequences for product design, retail experience, medical research priorities, and political coalition-building in legalization fights still underway in states like Pennsylvania, North Carolina, and Hawaii.

Advertisement

Pregnancy, Perimenopause, and the Hard Conversations

One of the most challenging segments in Weed 8 tackles cannabis use during pregnancy. Gupta's reporting acknowledges what clinicians have been documenting for years: pregnant patients are increasingly turning to cannabis to manage nausea, anxiety, and sleep, sometimes in lieu of pharmaceutical options they consider riskier. At the same time, a growing body of research suggests prenatal THC exposure may influence fetal brain development in ways that researchers are only beginning to map.

The special also explores cannabis and perimenopause, a topic that has rapidly moved from women's-wellness blogs into mainstream medical conversation. As clinicians look for non-hormonal options to help patients manage hot flashes, sleep disruption, and anxiety symptoms during the menopausal transition, low-dose cannabis and CBD products have emerged as one of the most-asked-about adjuncts — and one of the least-studied. CNN's coverage offers an early-mainstream window into a research conversation that is moving fast.

A Cultural Moment, Just Ahead of 4/20

The timing of the Weed 8 premiere — Sunday, April 19, the night before 4/20 — is no accident. CNN is positioning the special as cultural agenda-setting just as cannabis culture's biggest commercial weekend kicks into gear. Dispensaries from coast to coast will be running 4/20 promotions Monday; major festivals including SweetWater 420 Fest in Atlanta, Mile High 420 in Denver, and Hippie Hill in San Francisco are clustering around the same long weekend; and brands across categories are pushing 4/20 campaigns explicitly aimed at women — wellness, beverage, microdose, and sleep products in particular.

For viewers, the timing means Weed 8 doubles as an unusually well-produced "what's actually happening with weed in 2026" briefing in advance of the busiest cannabis news cycle of the year. For the broader cannabis industry, it is free national distribution of a narrative the sector has been trying to amplify on its own for years.

How to Watch and What to Expect

Weed 8: Women and Weed premieres Sunday, April 19, 2026 at 8 p.m. ET/PT on CNN, with replays scheduled throughout the week. The hour will stream the next day for subscribers of CNN's streaming offering. Listeners and viewers can also expect tie-in coverage across CNN Health and CNN.com, including reader Q&As and short-form video segments on cannabis and perimenopause that have been previewed online.

For longtime fans of the Weed series, Weed 8 is the installment that finally puts women at the center of the cannabis story. For everyone else, it is a fast, accessible primer on the cultural and clinical questions that will define the next phase of legal cannabis in the United States.

Key Takeaways

  • Weed 8: Women and Weed, the eighth installment in Dr. Sanjay Gupta's CNN cannabis documentary series, premieres April 19, 2026 at 8 p.m. ET/PT.
  • The hour focuses on women in cannabis: Cannamoms communities, women-led brands, the "grass ceiling," and clinical questions around pregnancy and perimenopause.
  • Gupta reports from Oklahoma — including the Cowboy Cup competition — and embeds with women shaping the industry as consumers, entrepreneurs, and advocates.
  • The premiere is timed to the night before 4/20, positioning CNN's coverage as cultural agenda-setting for the cannabis industry's largest commercial weekend.
  • Women have recently outpaced men as cannabis consumers in the U.S., a shift that Weed 8 argues will reshape product design, regulation, and capital flows in 2026 and beyond.

Explore cannabis news, find dispensaries, and join the community at Budpedia.

Budpedia Weekly

Liked this? There's more every Friday.

The Budpedia Weekly: cannabis laws, science, deals, and strain reviews in your inbox.